Table 4.

Linear Regression to Compare Mean Differences at Weeks 12 and 24 for Point Prevalence Abstinence^a,b

Variable	Placeboc	Treatmentc	Point estimate (90% CI)	P value
Week 12	n=23	n=20
Weight (kg)	2.5±4.3	1.5±2.5	−1.0 (−2.8 to 0.9)	.39
Waist circumference (cm)	2.0±5.4	−0.1±3.7	−2.1 (−4.5 to 0.3)	.15
BMI (kg/m2)	0.9±1.5	0.5±0.9	−0.4 (−1.0 to 0.2)	.29
Fat mass (kg)	1.8±3.4	1.4±2.2	−0.4 (−1.9 to 1.1)	.67
Week 24	n=15	n=11
Weight (kg)	2.5±9.1	1.4±2.7	−1.2 (−6.0 to 3.7)	.69
Waist circumference (cm)	2.9±8.9	−1.5±4.2	−4.4 (−9.4 to 0.5)	.14
BMI (kg/m2)	1.1±3.2	0.5±1.0	−0.6 (−2.3 to 1.1)	.55
Fat mass (kg)	1.9±7.8	1.5±3.0	−0.5 (−4.8 to 3.8)	.85

^aBMI, body mass index.

^bData are presented as Δmean ± SD unless indicated otherwise.

^cAverage change between baseline and week 12 or week 24.